Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

NCT02547844 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV-1

Interventions

DRUG: efavirenz + emtricitabina + tenofovir
DRUG: rilpivirina + emtricitabina + tenofovir

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators

[object Object]